Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Lipid Metabolism Deficiency NGS Panel Fulgent Genetics United States | 80 | 71 |
|
Fulgent Genetics United States | 30 | 5 |
|
Comprehensive Hearing Loss NGS Panel Fulgent Genetics United States | 332 | 167 |
|
Fulgent Genetics United States | 509 | 275 |
|
B-Negative Severe Combined Immunodeficiency NGS Panel Fulgent Genetics United States | 73 | 13 |
|
Fulgent Genetics United States | 505 | 132 |
|
Nonsyndromic Hearing Loss NGS Panel Fulgent Genetics United States | 146 | 99 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Severe Combined Immunodeficiency NGS Panel Fulgent Genetics United States | 330 | 90 |
|
Neuronal Migration Disorders NGS Panel Fulgent Genetics United States | 392 | 83 |
|
Fulgent Genetics United States | 163 | 75 |
|
Oxidative Phosphorylation Disorders NGS Panel Fulgent Genetics United States | 416 | 235 |
|
Hypomyelinating Leukodystrophy NGS Panel Fulgent Genetics United States | 225 | 62 |
|
Fulgent Genetics United States | 133 | 56 |
|
Fulgent Genetics United States | 533 | 149 |
|
Brain-Iron Accumulation NGS Panel Fulgent Genetics United States | 36 | 13 |
|
Cerebral Cortical Malformation NGS Panel Fulgent Genetics United States | 210 | 42 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.